Evidence map›Paper›PMID 35529082›Full record

ArticleInternational journal of endocrinology2022

Discriminatory Value of Adiponectin to Leptin Ratio for COVID-19 Pneumonia.

Federica Tonon, Stefano Di Bella, Fabiola Giudici, Verena Zerbato, Ludovica Segat, Raffaella Koncan, Andrea Misin, Barbara Toffoli, Pierlanfranco D'Agaro, Roberto Luzzati and 2 more

Abstract read
In one paragraph

Article in International journal of endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Reviving the mutual impact of SARS-COV-2 and obesity on patients: From morbidity to mortality.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
    Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Federica TononDepartment of Medical Surgical and Health Sciences, University of Trieste, Trieste 34149, Italy.
Stefano Di BellaDepartment of Medical Surgical and Health Sciences, University of Trieste, Trieste 34149, Italy.
Fabiola GiudiciGustave-Roussy, Bureau Biostatistique et Epidémiologie - 114, Rue Eduard Vaillant, Villejuif 94805, France.
Verena ZerbatoSC Malattie Infettive, Ospedale Maggiore, Azienda Sanitaria Universitaria Isontino-Giuliana, Trieste 34125, Italy.
Ludovica SegatU.C.O. Igiene e Sanità Pubblica, Ospedale Maggiore, Azienda Sanitaria Universitaria Isontino-Giuliana, Trieste 34125, Italy.
Raffaella KoncanDepartment of Medical Surgical and Health Sciences, University of Trieste, Trieste 34149, Italy.
Andrea MisinSC Malattie Infettive, Ospedale Maggiore, Azienda Sanitaria Universitaria Isontino-Giuliana, Trieste 34125, Italy.
Barbara ToffoliDepartment of Medical Surgical and Health Sciences, University of Trieste, Trieste 34149, Italy.
Pierlanfranco D'AgaroDepartment of Medical Surgical and Health Sciences, University of Trieste, Trieste 34149, Italy.
Roberto LuzzatiDepartment of Medical Surgical and Health Sciences, University of Trieste, Trieste 34149, Italy.
Bruno FabrisDepartment of Medical Surgical and Health Sciences, University of Trieste, Trieste 34149, Italy.
Stella BernardiDepartment of Medical Surgical and Health Sciences, University of Trieste, Trieste 34149, Italy.ORCID https://orcid.org/0000-0002-7429-3075

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Obesity is a risk factor for severe coronavirus disease 2019 (COVID-19). Circulating adipokines have been associated with inflammatory burden and amplified or dysregulated immune responses. This study aimed to evaluate the discriminatory ability of adipokines to identify COVID-19 pneumonia and to assess disease severity. Methods: We conducted an observational case-control study, with a prospective design, and recruited patients with diagnosis of COVID-19 pneumonia ( Results: Patients with COVID-19 pneumonia had higher levels of leptin, lower adiponectin/leptin (Adpn/Lep) ratio, and higher expression of IL-6. Leptin had an acceptable discriminatory accuracy for COVID-19 pneumonia in patients with BMI >30 (AUC 0.74 [0.58, 0.90]) with a cutoff of 7852 pg/mL and it was associated with maximum respiratory support. By contrast, Adpn/Lep had an excellent discriminatory accuracy for COVID-19 pneumonia in patients with BMI <25 (AUC 0.9 [0.74, 1.06]) with a cutoff of 2.23. Conclusion: Our data indicate that high Adpn/Lep (>2.23) in lean patients is consistent with a state of good health, which decreases in case of inflammatory states, ranging from adipose tissue dysfunction with low-grade inflammation to COVID-19 pneumonia.

Identifiers

PMID35529082
PMCPMC9072020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.